Search
Close this search box.

A payload-linker generating machine to quickly move from small molecules to characterized tool ADCs and PDCs

Print Friendly, PDF & Email

R. Lupi, P. Orsini, M. Salsa, S. Rizzi, U. Cucchi, D. Faiardi, A. Burocchi, A. Ciavolella, F. Gasparri, B. Valsasina
14th World ADC London 2024; March 12-15, 2024; London, UK

Discovery of NMS-0963, a potent, selective and orally available Syk inhibitor with outstanding preclinical activity in diffuse large B-cell lymphoma
Development of 14-amino-anthracyclines as novel payloads for ADC production showing potent anti-tumor activity and improved safety profile
Nerviano MS Logo

Follow Us on

Nerviano Medical Sciences S.r.l. 

Viale Luigi Pasteur 10
20014 Nerviano (MI)
Italy

Share Capital: € 1,200,000.00
fully paid-in

Company subject to the management and coordination of NMS Group S.p.A.

Copyright © 2024 Nerviano Medical Sciences S.r.l
Website by Axxiem

Share this page

Facebook
Twitter
LinkedIn
Email
svg.e-font-icon-svg {display:none!important} .elementor-button-icon {display:none!important} .show-more, .show-more2 {display:none!important} img.pf-large-image.pf-primary-img.flex-width.pf-size-full.blockImage { display: none!important; }